| |
Original Artikel |
Journal |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
Pharmaceutical Sciences Asia |
2023―Aug―11 |
ABO blood group and effectiveness of tocilizumab in clinical response to COVID-19: A single center, retrospective study |
Izza Aulia Rizqika Nasution, Retnosari Andrajati, Nadia Farhanah Syafhan, Rania Imaniar |
| 2 |
[GO] |
Pharmaceutical Sciences Asia |
2023―Jan―19 |
Simulation of pharmacokinetic drug-drug interaction and dosage regimens optimization of nelfinavir and cepharanthine as a potential combination against COVID-19 |
Wichit Nosoongnoen |
| 3 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Aug―05 |
Pharmacists' willingness to administer COVID-19 vaccine: A survey from Yogyakarta community pharmacists |
Susi Ari Kristina, Hardika Aditama, Meita Annisa |
| 4 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Jul―22 |
Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019 |
Kiatkriangkrai Koyratkoson, Nattapong Tidwong, Suwida Tangtrakultham, Preecha Montakantikul |
| 5 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Jul―22 |
Cell culture models for SARS-CoV-2 infectivity and systemic complications |
Khanit Sa-ngiamsuntorn, Piyanoot Thongsri, Yongyut Pewkliang, Adisak Wongkajornsilp |
| 6 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Mrz―07 |
Exploring the role of community pharmacists in preventing the onsite infection during COVID-19 pandemic |
Noor Raouf Al-Hasani, Dheyaa JabbarKadhim, Ali Azeez Al-Jumaili |
| 7 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Jan―04 |
Determinants of COVID-19 self-protection behavior of Thai people: a cross-sectional survey |
Benjawee Srithanissorn, Kritsana Yonphet, Daranee Chiewchantanakit, Witoo Dilokthornsakul, Piyameth Dilokthornsakul |
| 8 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Jan―04 |
Current data on Covid-19 vaccine in pediatrics |
Lalitphat Treerattanapun, Preecha Montakantikul |
| 9 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Jan―04 |
Are immunosuppressant related to unfavorable outcomes in patients COVID-19 with autoimmune rheumatic disease?: A review of clinical evidence |
Oki Nugraha Putra, Hardiyono Hardiyono, Mia Arum Anggraini |
| 10 |
[GO] |
Pharmaceutical Sciences Asia |
2022―Jan―04 |
Optimizing hydroxychloroquine dosing regimen for treatment of pediatric patients with coronavirus disease 2019 using Monte Carlo simulation |
Lalitphat Treerattanapun, Suwida Tangtrakultham, Nattapong Tidwong, Preecha Montakantikul |
| 11 |
[GO] |
Pharmaceutical Sciences Asia |
2021―Sep―01 |
Optimized dosing regimen of hydroxychloroquine for treatment of coronavirus disease 2019 using Monte Carlo simulation |
Sumit Leevanichchakhul, Pitchaya Dilokpattanamongko, Taniya Paiboonvong, Suwida Tangtrakultham, Supatat Chumnumwat, Sasisopin Kiertiburanaku, Preecha Montakantikul |
| 12 |
[GO] |
Pharmaceutical Sciences Asia |
2021―Jul―20 |
Optimized chloroquine phosphate dosage regimens for early virological clearance of severe acute respiratory syndrome coronavirus 2 using Monte Carlo simulation |
Nattapong Tidwong, Baralee Punyawudho, Pannee Leelawattanachai, Suwida Tangtrakultham, Pitchaya Dilokpattanamongkol, Taniya Paiboonvong, et al. (+2) Supatat Chumnumwat, Preecha Montakantikul |
| 13 |
[GO] |
Pharmaceutical Sciences Asia |
2020―Apr―15 |
Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection) |
Nattapong Tidwong, Preecha Montakantikul, Weerawat Manosuthi |
